Health Services Research
Latest posts by Health Services Research (see all)
- Effects of the Ten Percent Cap in Medicare Home Health Care on Treatment Intensity and Patient… - Mar. 02, 2015
- Acceptance of New Medicaid Patients by Primary Care Physicians and Experiences with Physician… - Feb. 13, 2015
- Regional Growth in Medicare Spending, 1992–2010 - Feb. 12, 2015
- Does Higher Spending Improve Survival Outcomes for Myocardial Infarction? Examining the… - Feb. 09, 2015
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.